Literature DB >> 8577452

The blood-aqueous barrier in eyes with pseudoexfoliation syndrome.

M Küchle1, N X Nguyen, E Hannappel, G O Naumann.   

Abstract

UNLABELLED: Eyes with pseudoexfoliation syndrome (PEX) frequently show clinical signs of impairment of the blood-aqueous barrier. Herein we give an overview of recent studies that analyzed the blood-aqueous barrier in eyes with PEX.
METHODS: The authors review and summarize recent studies including quantification of aqueous flare in eyes with PEX using the laser flare cell meter (LFCM; Kowa FC-1000) in comparison with normal eyes and eyes with primary open-angle glaucoma (POAG), quantification of aqueous flare in eyes with PEX with and without secondary open-angle glaucoma (SOAG), and quantitative biochemical determination of total aqueous protein concentration in PEX eyes. In addition, studies of noninvasive quantification of the blood-aqueous barrier breakdown following trabeculectomy and following phacoemulsification with intraocular lens implantation in eyes with and without PEX are reviewed.
RESULTS: In eyes with manifest PEX, both aqueous flare and aqueous protein concentration were significantly increased in comparison with normal control eyes and eyes with POAG. Flare values in PEX eyes with SOAG were not significantly different from flare values in PEX eyes without SOAG. Following trabeculectomy as well as following cataract surgery, breakdown of the blood-aqueous barrier as determined by quantification of aqueous flare was significantly higher in eyes with PEX than in eyes without PEX.
CONCLUSIONS: Impairment of the blood-aqueous barrier with increase in aqueous protein concentration is a feature of PEX and may be quantified both by flare measurement and by biochemical protein determination. The extensive blood-aqueous barrier breakdown in eyes with PEX following intraocular surgery is an important risk factor for early or late postoperative complications. The alterations of the blood-aqueous barrier should be considered in the medical and surgical treatment of eyes with PEX.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8577452     DOI: 10.1159/000267859

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  24 in total

1.  Anterior chamber aqueous flare, pseudoexfoliation syndrome, and glaucoma.

Authors:  Rim Kahloun; Sonia Attia; Imen Ksiaa; Ilhem Kacem; Ines Bouanene; Sonia Zaouali; Bechir Jelliti; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2016-01-19       Impact factor: 2.031

Review 2.  The medical and surgical management of pseudoexfoliation glaucoma.

Authors:  Manishi A Desai; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2008

Review 3.  Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology.

Authors:  Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2016-11-25       Impact factor: 2.447

Review 4.  [PEX syndrome. Clinical diagnosis and systemic manifestations].

Authors:  E Scharfenberg; U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

Review 5.  [Diagnosis and therapy of pseudoexfoliation glaucoma].

Authors:  A G M Jünemann
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

6.  Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma.

Authors:  Matthias Zenkel; Piotr Lewczuk; Anselm Jünemann; Friedrich E Kruse; Gottfried O H Naumann; Ursula Schlötzer-Schrehardt
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 7.  Prospects for gene-environment interactions in exfoliation syndrome.

Authors:  Louis R Pasquale; Jae H Kang; Janey L Wiggs
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

8.  Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome.

Authors:  Sabina Janciauskiene; Torsten Krakau
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

9.  Comparison of long-term results of trabeculectomy to treat pseudoexfoliative glaucoma and primary open angle glaucoma.

Authors:  Vuslat Pelitli Gürlü; Hande Güçlü; Altan Özal; Ömer Benian; Levent Alimgil
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

10.  A prospective study of folate, vitamin B₆, and vitamin B₁₂ intake in relation to exfoliation glaucoma or suspected exfoliation glaucoma.

Authors:  Jae H Kang; Stephanie J Loomis; Janey L Wiggs; Walter C Willett; Louis R Pasquale
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.